(Total Views: 522)
Posted On: 08/08/2023 10:43:27 AM
Post# of 148903
Quote:
"Merck has expanded its oncology collaboration with Otsuka subsidiary Astex Pharmaceuticals to the tune of a $35 million upfront payment and potential milestone payments of $500 million per program.
Astex will use its fragment-based discovery platform to find small molecules to target the p53 tumor suppressor protein before handing off potential candidates to Merck for the funding and research, development, and potential commercialization."
This is behind a paywall of that website that Feuerstein is involved with.
https://endpts.com/merck-expands-deal-with-as...discovery/
(0)
(0)Scroll down for more posts ▼
